Bioboost Synbio Secure Key Patent in the United States

Bioboost Synbio Inc. (www.bioboostsynbio.com) received their Notice of Allowance from the United States Patent and Trademark Office (USPTO) to secure their first patent in the USA.

Bioboost is a synthetic biology company with a patented biosynthesis platform that is scalable, cost effective, and sustainable to produce high value biologics. Bioboost’s technology removes a major roadblock in the large-scale industrial pichia yeast fermentation, while improving expression and high titers of the target molecules.

Securing their patent in the US is a critical step to get Bioboost Synbio on the map with their clean, sustainable and powerful technology platform to biosynthesize high value proteins like recombinant human SOD3, human EGF, lactoferrin and more for different markets.

Bioboost Synbio are simultaneously initiating their patent application in Canada, China and Europe via PPH (Patent Prosecution Highway) process to expand their IP protection to strategic regions/countries around the world.

Source: Bioboost Synbio